| H group (n = 64) | N group (n = 51) | P value |
---|---|---|---|
Age (years) | Â | Â | Â |
 Median (IQR) | 68 (40–85) | 65 (27–80) | 0.381 |
Gender, n (%) | Â | Â | Â |
 Male | 47 (72) | 32 (63) | 0.232 |
 Female | 17 (28) | 19 (27) |  |
Serum albumin level (g/dl) | Â | Â | Â |
 Median (IQR) | 4.1 (3.3–5.0) | 4.1 (3.2–4.9) | 0.378 |
ASA score, n (%) | Â | Â | Â |
 1 | 20 (31) | 12 (24) | 0.646 |
 2 | 40 (63) | 35 (68) |  |
 3 | 4 (6) | 4 (8) |  |
PNI | Â | Â | Â |
 Median (IQR) | 47.2 (38.7–58.3) | 49.4 (35.9–59.2) | 0.113 |
CRP | Â | Â | Â |
 Median (IQR) | 0.1 (0.01–7.24) | 0.08 (0.01–4.14) | 0.504 |
mGPS, n (%) | Â | Â | Â |
 0 | 54 (84) | 39 (76) | 0.373 |
 1 | 9 (14) | 9 (18) |  |
 2 | 1 (2) | 3 (6) |  |
BMI | Â | Â | Â |
 Median (IQR) | 21.9 (14.7-30.4) | 20.7 (16.1-27.4) | 0.030 |
Primary tumour location, n (%) | Â | Â | Â |
 Colon | 44 (69) | 33 (65) | 0.693 |
 Rectum | 20 (31) | 18 (35) |  |
Tumour location, n (%) | Â | Â | Â |
 Unilobe | 30 (47) | 19 (27) | 0.345 |
 Bilobe | 34 (53) | 32 (63) |  |
Tumour size (mm) | Â | Â | Â |
 Median (IQR) | 33.5 (5–120) | 27 (7–80) | 0.156 |
Number of tumours | Â | Â | Â |
 Median (IQR) | 3 (1–30) | 4 (1–12) | 0.677 |
Detection of metastasis, n (%) | Â | Â | Â |
 Synchronous | 30 (47) | 30 (59) | 0.260 |
 Metachronous | 34(53) | 21 (41) |  |
CEA (ng/dl) | Â | Â | Â |
 Median (IQR) | 8.3 (1.3–855) | 4.3 (1.1–718) | 0.504 |
CA19-9 (mU/l) | Â | Â | Â |
 Median (IQR) | 27 (1–2368) | 14 (1–984) | 0.477 |
Preoperative chemotherapy, n (%) | Â | Â | Â |
 Yes | 41 (64) | 30 (59) | 0.700 |
 No | 23 (36) | 21 (41) |  |
Postoperative chemotherapy, n (%) | Â | Â | Â |
 Yes | 24 (38) | 24 (47) | 0.302 |
 No | 40 (62) | 27 (53) |  |
Other organ metastasis, n (%) | Â | Â | Â |
 Yes | 11 (17) | 9 (17) | 1.000 |
Surgical margin, n (%) | Â | Â | Â |
 Yes | 12 (18) | 9 (18) | 1.000 |
 No | 52 (82) | 42 (82) |  |
Surgical procedure, n (%) | Â | Â | Â |
 Major resection | 20 (39) | 14 (28) | 0.686 |
 Minor resection | 44 (61) | 37 (72) |  |
Synchronous resection for primary tumour | Â | Â | Â |
 Yes | 4 (8) | 5 (8) | 0.481 |
Operation time (min) | Â | Â | Â |
 Median (IQR) | 427 (198–783) | 432 (229–797) | 0.934 |
Operative blood loss (ml) | Â | Â | Â |
 Median (IQR) | 515 (0–2257) | 526 (10–1975) | 0.934 |
PMI | Â | Â | Â |
 Median (IQR) |  |  |  |
  Male | 6.2 (1.8–10.1) | 6.1 (3.8–10.1) | 0.892 |
  Female | 4.4 (2.2–10.7) | 4.4 (2.3–10.7) | 1.000 |
Post-op complication ≥ C-D grade 2 |  |  |  |
 Yes, n (%) | 20 (31) | 12 (23) | 0.407 |
Post-op complication ≥ C-D grade 3 |  |  |  |
 Yes, n (%) | 11 (17) | 1 (1.9) | 0.011 |